Inogen, Inc. (FRA:6IO)

Market Cap	168.26M -18.4%
Revenue (ttm)	310.12M +3.2%
Net Income	-21.53M
EPS	-0.81
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	89
Open	6.20
Previous Close	5.85
Day's Range	6.20 - 6.20
52-Week Range	4.38 - 7.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airw...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 753
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6IO

Financial Performance

In 2025, Inogen's revenue was $348.67 million, an increase of 3.86% compared to the previous year's $335.71 million. Losses were -$22.75 million, -36.62% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error